First reason for hope: the number of cancer deaths is down slightly in our country, thanks to earlier diagnoses and more effective treatments.
The fact remains that with 380,000 new cases diagnosed each year, cancer remains the leading cause of premature death in France.
An enemy to fight against which research is mobilizing on all fronts.
As in war, you must first know your adversary.
So better decipher the genome of the tumor to better destroy it.
“Thanks to the performance of
, we can identify the genetic mutations that trigger cancer, and therefore direct treatment more effectively.
These genomic tests are now essential for the personalized treatment of many cancers,”
explains Professor Jean-Yves Blay, medical oncologist, general manager of the Léon-Bérard Center and president of Unicancer.
Cancers: “signatures” to draw a more precise portrait of tumors
There remains the financial problem: prices soar when they have the ability to detect…
This article is for subscribers only.
You have 92% left to discover.
Pushing back the limits of science is also freedom.
Keep reading your article for €0.99 for the first month
I ENJOY IT